Colloidal iodine is a new type of immunotherapy that has a completely different mechanism of action than checkpoint inhibitors. Biogenetical modulation regulates the formation of the gene-cancer ...
TOKYO, June 22, 2020 /PRNewswire/ -- On June 10, 2020, JCI MN IODINE Co., Ltd. released the following new information regarding the therapeutic usefulness of JCI MN IODINE agents. Ryusuke Fujiki, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results